We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA issues highly-anticipated Draft Guidance on the 510(k) Program

12 January 2012

Medical Device Alert

On 27 December 2011, the Food and Drug Administration (FDA or "the Agency") issued a new draft guidance document on the 510(k) program titled Draft Guidance for Industry and Food and Drug Administration Staff: The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] ("Draft 510(k) Paradigm Guidance" or "the new guidance"). The Draft 510(k) Paradigm Guidance clarifies key aspects of the substantial equivalence standard at the heart of the 510(k) program that, over the last few years, have attracted significant attention. It also sets forth new policies regarding Special 510(k) submissions, and clarifies when it is appropriate for manufacturers to submit Abbreviated 510(k) submissions to FDA. The Agency is seeking comments on the draft guidance by 26 April 2012.

Read: "FDA issues highly-anticipated Draft Guidance on the 510(k) Program"

The team

Loading data